The New York side of the reporting late last night had Alfonso Soriano to the Yankees as all but a done deal. The Chicago side, however, has come out today saying that discussions have been had but that it is not imminent.
On MLB Network Radio today, Jed Hoyer said such reports are “very premature” and that there is “nothing close at all.” This is backed up by other reports saying that the talks are preliminary.
So, New York scribes: you may have to wait a day or two for that column in which you talk about how refreshing it is that the man who was once traded for Alex Rodriguez is coming back to breathe a breath of fresh air back into the Bronx or whatever it is you have planned.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.